This list is an analysis based on recent market events. It's not an investment recommendation.
About
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
The current price of PSRX.TA is ILA63.00 ILA — it has decreased by -5.97% in the past 24 hours. Watch PsyRx CNS Bio-Tech stock price performance more closely on the chart.
What is PsyRx CNS Bio-Tech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tel Aviv Exchange exchange PsyRx CNS Bio-Tech stocks are traded under the ticker PSRX.TA.
How many employees does PsyRx CNS Bio-Tech have?▼
As of November 2, 2026, the company has 6 employees.
In which sector is PsyRx CNS Bio-Tech located?▼
PsyRx CNS Bio-Tech operates in the Health & Wellness sector.
When did PsyRx CNS Bio-Tech complete a stock split?▼
The last stock split for PsyRx CNS Bio-Tech was on January 21, 2025 with a ratio of 1:10.
Where is PsyRx CNS Bio-Tech headquartered?▼
PsyRx CNS Bio-Tech is headquartered in Tel Aviv-Jaffa, Israel.